Form 4: TransAct Director Audrey Dunning Receives Equity Grant

Sentiment:

Insider Transaction Report


TransAct Technologies Director Audrey Dunning was granted 14,700 Restricted Stock Units, vesting on the first anniversary of the February 24, 2026 grant date.

Summary

  • Audrey Dunning, a Director of TransAct Technologies Inc. (TACT), received a grant of 14,700 Restricted Stock Units (RSUs).
  • The RSUs were issued on February 24, 2026, pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated.
  • These RSUs will cliff vest on the first anniversary of the grant date, which is February 24, 2027.
  • Upon vesting, the RSUs convert to common stock on a one-for-one basis.
  • Following this transaction, Audrey Dunning beneficially owns 11,475 shares of Common Stock directly and 14,700 Restricted Stock Units directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard director compensation practices that align insider interests with long-term company performance.

Positives

  • The grant of 14,700 Restricted Stock Units to a director aligns their long-term interests with those of shareholders.
  • The use of an equity incentive plan demonstrates a commitment to retaining key personnel and incentivizing long-term performance.

Future Outlook

The 14,700 Restricted Stock Units granted to Director Audrey Dunning are scheduled to cliff vest on February 24, 2027, the first anniversary of the grant date, and will convert to common stock on a one-for-one basis.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice across industries to incentivize long-term commitment and align interests with shareholders. This particular grant is standard for director compensation within the technology sector.

Comparison to Industry Standards

  • Equity compensation for directors is a standard practice in publicly traded companies, aligning director interests with shareholder value.
  • The grant of 14,700 RSUs to a director at TransAct Technologies is within typical ranges for non-executive director compensation in small to mid-cap technology companies, comparable to similar grants seen at companies like NCR Corporation or PAR Technology Corporation, which also operate in specialized technology solutions.

Related Party Transactions

  • Grant of 14,700 Restricted Stock Units to Audrey Dunning, a Director of TransAct Technologies Inc., as part of her compensation under the Company's 2014 Equity Incentive Plan.

Stakeholder Impact

  • Shareholders: Aligns the director's interests with long-term shareholder value through equity ownership. Potential future dilution from stock issuance upon RSU vesting is minimal.
  • Employees: May signal a stable and competitive compensation strategy for key personnel within the company.

Next Steps

  • Vesting of 14,700 Restricted Stock Units on February 24, 2027.
  • Conversion of vested RSUs into common stock on a one-for-one basis.

Key Dates

DateDescription
10/30/2025Date of execution of the Power of Attorney by Audrey P. Dunning.
02/24/2026Date of the Restricted Stock Unit grant to Audrey Dunning.
02/26/2026Date the Form 4 was signed by the attorney-in-fact for Audrey Dunning.
02/24/2027Estimated cliff vesting date for the 14,700 Restricted Stock Units (first anniversary of grant).

Recommendation

hold

The grant of Restricted Stock Units to a director is a routine compensation event that aligns the director's long-term interests with those of shareholders. It does not provide new material information about the company's operational or financial performance that would significantly alter an investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

TACT, TransAct Technologies, Audrey Dunning, Restricted Stock Units, RSU, Insider Transaction, Form 4, Equity Incentive Plan, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.